验证数据展示
经过测试的应用
| Positive IHC detected in | mouse brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
推荐稀释比
| 应用 | 推荐稀释比 |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
产品信息
Biotin-10833 targets EPHX2 in IHC applications and shows reactivity with human, mouse, rat samples.
| 经测试应用 | IHC Application Description |
| 经测试反应性 | human, mouse, rat |
| 免疫原 | EPHX2 fusion protein Ag1283 种属同源性预测 |
| 宿主/亚型 | Rabbit / IgG |
| 抗体类别 | Polyclonal |
| 产品类型 | Antibody |
| 全称 | epoxide hydrolase 2, cytoplasmic |
| 别名 | |
| 计算分子量 | 63 kDa |
| 观测分子量 | 63 kDa |
| GenBank蛋白编号 | BC013874 |
| 基因名称 | EPHX2 |
| Gene ID (NCBI) | 2053 |
| RRID | AB_3672368 |
| 偶联类型 | Biotin |
| 形式 | Liquid |
| 纯化方式 | Antigen affinity purification |
| UNIPROT ID | P34913 |
| 储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3 |
| 储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
EPHX2(Epoxide hydrolase 2) acts on epoxides (alkene oxides, oxiranes) and arene oxides and plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. A number of single nucleotide polymorphisms (SNPs) in human EPHX2 have been linked to cardiovascular disease risk, including increased risk of coronary heart disease, hyperlipoproteinemia, and type-2 diabetes (PMID: 14732757, 16595607, 14673705, 15845398, 17460077). It was observed in many tissues with the band of 63 kDa in the western blot. It has also been reported that the N-terminal domain might promote dimerization of EPHX2 (PMID:21553642).
实验方案
| Product Specific Protocols | |
|---|---|
| IHC protocol for Biotin EPHX2 antibody Biotin-10833 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |